A Stylet device that allows for the articulation of tubing and provides a method for positioning of the tubing during intubation or other procedures while the tubing is located within a passage-way or lumen of a subject, such as an airway, organs, veins, intestines and the like. Where unique anatomical conditions are present in a subject, rendering standard intubation devices inadequate, the articulation capabilities of the apparatuses of the current invention are of particular use during methods of use and further promote the non-occlusion of the central cavity of the tube.

A first source of medical gas has a generally cylindrical male outlet with a cylindrical bore and a threaded outer cylindrical surface. A flexible cylindrical elastomeric medical gas tubing has an input end with a bushing making a flush abutment with the male outlet at the output orifice. An output end attaches to any of a plurality of medical gas utilizing devices, but preferably with a dampening disperser held in position in the space in the vicinity of a patient's nose and mouth. An annular flange of the input end bushing resides within a central cylindrical bored out region extending through the first end and nearly to the second end of a rotatable connector forming an interior surface of a connector with threads coupling with the threads of the male outlet. The second end is an annular abutment against the annular flange holding the input end tubing bushing against the outlet source and providing an airtight coupling. A gripping means is on the exterior surface of the connector.

This disclosure provides a perfusion device, an anesthetic vaporizer, and an anesthetic machine. The anesthetic vaporizer includes a vaporizer body and the perfusion device. A feed port and a tank are provided in the vaporizer body. The perfusion device includes a mounting assembly, an ejector rod assembly, and a valve core assembly that is provided with a liquid inlet channel. The mounting assembly includes a mounting seat that is mounted on the feed port and provided with a hollow structure having an opening at both ends. The valve core assembly is movably mounted on one opening of the hollow structure, and the ejector rod assembly is movably mounted on the other opening of the hollow structure and forms a sealed structure with the mounting assembly. The ejector rod assembly may drive the valve core assembly to move toward the tank, and the liquid inlet channel communicates with the hollow structure.

Provided is a pharmaceutical agent for effective prophylaxis and/or treatment of a pathological condition with decreased lung compliance. The pharmaceutical agent for prophylaxis and/or treatment of a pathological condition with decreased lung compliance is characterized by having a polyamine. The polyamine includes at least one of spermine (Spm), spermidine (Spd), and putrescine (Put). The pharmaceutical agent improves lung compliance and ameliorates gas exchange dysfunction, and therefore, can ameliorate pathological conditions such as acute respiratory distress syndrome (ARDS), acute lung injury (ALI), lung diseases caused by dysfunctional endogenous pulmonary alveolar surfactant, multiple organ dysfunction syndrome (MODS), and cardiogenic pulmonary edema.

Module for housing electronic and electromechanical medical equipment including a portable digital camera and processing circuitry with machine vision and machine learning software for automatically documenting healthcare events and healthcare equipment operations in the electronic health record.

An anesthesia device configured to measure the hydrogen concentration in an anesthesia gas containing a hydrogen gas includes: an anesthesia gas preparation circuit configured to generate anesthesia gas by mixing an air or an oxygen mixture air with a vaporized anesthetic; a closed circuit-type or semi-closed circuit-type respiratory circuit including a gas circulation passage configured to circulate the hydrogen-containing anesthesia gas containing the hydrogen gas and the vaporized anesthetic; and a hydrogen concentration measurement circuit configured to measure the hydrogen concentration in the hydrogen-containing anesthesia gas in the gas circulation passage, wherein the hydrogen concentration measurement circuit includes: an anesthetic removing member having a removability of the vaporized anesthetic in the hydrogen-containing anesthesia gas; and a hydrogen concentration measuring instrument provided on the secondary side of the anesthetic removing member.

An anesthesia device configured to measure the hydrogen concentration in an anesthesia gas containing a hydrogen gas includes: an anesthesia gas preparation circuit configured to generate anesthesia gas by mixing an air or an oxygen mixture air with a vaporized anesthetic; a closed circuit-type or semi-closed circuit-type respiratory circuit including a gas circulation passage configured to circulate the hydrogen-containing anesthesia gas containing the hydrogen gas and the vaporized anesthetic; and a hydrogen concentration measurement circuit configured to measure the hydrogen concentration in the hydrogen-containing anesthesia gas in the gas circulation passage, wherein the hydrogen concentration measurement circuit includes: an anesthetic removing member having a removability of the vaporized anesthetic in the hydrogen-containing anesthesia gas; and a hydrogen concentration measuring instrument provided on the secondary side of the anesthetic removing member.

A method of treatment for mixed carbon dioxide, carbonic acid, saline and optional active additives for treating lower body cavity ailments includes delivery of dosage of the treatment at specified flow rates, using a) main housing having a hollow central area containing the dosage; b) a dosage dispenser head located at the distal end of the main housing, and having at least one flow channel for movement of the dosage from the main housing through the dosage dispenser head and to external of the dosage dispenser head; c) a dosage release control component located between the main housing and the dosage dispenser head to permit flow of the dosage through the dosage dispenser head in response to increased pressure against the dosage; and d) a pressure-changing moveable component on the main housing.

A method of treatment for mixed carbon dioxide, carbonic acid, saline and optional active additives for treating lower body cavity ailments includes delivery of dosage of the treatment at specified flow rates, using a) main housing having a hollow central area containing the dosage; b) a dosage dispenser head located at the distal end of the main housing, and having at least one flow channel for movement of the dosage from the main housing through the dosage dispenser head and to external of the dosage dispenser head; c) a dosage release control component located between the main housing and the dosage dispenser head to permit flow of the dosage through the dosage dispenser head in response to increased pressure against the dosage; and d) a pressure-changing moveable component on the main housing.

Medical gas delivery devices are provided. A garment or another object may include a hose assembly configured to couple the garment or the object to a medical gas source. The garment or the object can be configured to deliver a medical gas to a patient. Additionally, medical gas delivery devices configured to be removably coupled to a garment or another object are provided.